Literature DB >> 23385082

Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).

Anna Lieu1, Gustavo Tenorio, Bradley J Kerr.   

Abstract

In the spinal cord, PKCγ is an important kinase found in a specific subset of excitatory interneurons in the superficial dorsal horn and in axons of the corticospinal tract (CST). The major interest in spinal PKCγ has been its influences on regulating pain sensitivity but its presence in the CST also indicates that it has a significant role in locomotor function. A hallmark feature of the animal model commonly used to study Multiple Sclerosis, experimental autoimmune encephalolomyelitis (EAE) are motor impairments associated with the disease. More recently, it has also become recognized that EAE is associated with significant changes in pain sensitivity. Given its role in generating pain hypersensitivity and its presence in a major tract controlling motor activity, we set out to characterize whether EAE was associated with changes PKCγ levels in the spinal cord. We show here that EAE triggers a significant reduction in the levels of PKCγ, primarily in the CST. We did not observe any significant changes in PKCγ levels in the superficial dorsal horn but in general the levels tended to be below control levels in this region. In a final experiment we assessed the levels of PKCγ in the spinal cord of EAE mice that had recovered gross locomotor function and compared this to the levels found in EAE mice with chronic deficits. Our findings demonstrate that PKCγ levels are dynamic and that in later stages of the disease, its expression is dependent on the degree of motor function in the model. Taken together these results suggest that PKCγ may be a useful marker in the disease to monitor the status of the CST.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385082     DOI: 10.1016/j.jneuroim.2013.01.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

2.  KIF2A characterization after spinal cord injury.

Authors:  Oscar Seira; Jie Liu; Peggy Assinck; Matt Ramer; Wolfram Tetzlaff
Journal:  Cell Mol Life Sci       Date:  2019-04-30       Impact factor: 9.261

3.  Caudal-Rostral Progression of Alpha Motoneuron Degeneration in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Alastair J Kirby; Thomas Palmer; Richard J Mead; Ronaldo M Ichiyama; Samit Chakrabarty
Journal:  Antioxidants (Basel)       Date:  2022-05-17

4.  A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice.

Authors:  Natalie H Guley; Joshua T Rogers; Nobel A Del Mar; Yunping Deng; Rafiqul M Islam; Lauren D'Surney; Jessica Ferrell; Bowei Deng; Jessica Hines-Beard; Wei Bu; Huiling Ren; Andrea J Elberger; Jeffrey G Marchetta; Tonia S Rex; Marcia G Honig; Anton Reiner
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

5.  Targeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2016-05-01       Impact factor: 5.996

6.  Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189.

Authors:  Anton Reiner; Scott A Heldt; Chaela S Presley; Natalie H Guley; Andrea J Elberger; Yunping Deng; Lauren D'Surney; Joshua T Rogers; Jessica Ferrell; Wei Bu; Nobel Del Mar; Marcia G Honig; Steven N Gurley; Bob M Moore
Journal:  Int J Mol Sci       Date:  2014-12-31       Impact factor: 5.923

7.  Rab32 connects ER stress to mitochondrial defects in multiple sclerosis.

Authors:  Yohannes Haile; Xiaodan Deng; Carolina Ortiz-Sandoval; Nasser Tahbaz; Aleksandra Janowicz; Jian-Qiang Lu; Bradley J Kerr; Nicholas J Gutowski; Janet E Holley; Paul Eggleton; Fabrizio Giuliani; Thomas Simmen
Journal:  J Neuroinflammation       Date:  2017-01-23       Impact factor: 8.322

8.  A cell-based drug delivery platform for treating central nervous system inflammation.

Authors:  Oren Levy; Veit Rothhammer; Ivan Mascanfroni; Zhixiang Tong; Rui Kuai; Michael De Biasio; Qingping Wang; Tahir Majid; Christelle Perrault; Ada Yeste; Jessica E Kenison; Helia Safaee; Juliet Musabeyezu; Martina Heinelt; Yuka Milton; Heidi Kuang; Haoyue Lan; William Siders; Marie-Christine Multon; Jonathan Rothblatt; Salam Massadeh; Manal Alaamery; Ali H Alhasan; Francisco J Quintana; Jeffrey M Karp
Journal:  J Mol Med (Berl)       Date:  2021-01-04       Impact factor: 4.599

Review 9.  Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.

Authors:  Nemat Khan; Maree T Smith
Journal:  Inflammopharmacology       Date:  2014-02       Impact factor: 4.473

10.  Toll-Like Receptors and Dectin-1, a C-Type Lectin Receptor, Trigger Divergent Functions in CNS Macrophages.

Authors:  John C Gensel; Yan Wang; Zhen Guan; Kyle A Beckwith; Kaitlyn J Braun; Ping Wei; Dana M McTigue; Phillip G Popovich
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.